This Overlooked Vanguard ETF Is Quietly Outperforming Its Rivals

The Vanguard Total International Stock ETF (VXUS) posted a 40% total return over the trailing 12 months, outperforming the Vanguard S&P 500 ETF and Vanguard Total Stock Market ETF, both of which were up about 32%. The article argues for adding a 5% allocation to international equities to reduce U.S. concentration risk amid high U.S. valuations, $40 trillion in debt, and tariff-driven supply chain shifts. Low fees of 0.05% and exposure to top holdings like Taiwan Semiconductor, Samsung, and ASML are presented as key positives.

Analysis

The setup is less about VXUS as a standalone product and more about a possible regime shift from U.S. exceptionalism to a broader dispersion trade. If that shift persists, the first-order winners are the foreign technology and capital-goods franchises that sit in the global semiconductor supply chain: TSM and ASML capture the highest-quality secular demand, while the second-order losers are U.S.-centric mega-cap growth names that have become crowded equity-duration proxies. The important nuance is that international equity outperformance can coexist with a weaker U.S. dollar; that combination would amplify foreign returns for U.S.-based allocators and could force systematic rebalancing flows into non-U.S. assets.

The market is likely underpricing how quickly foreign benchmarks can benefit from simple mean reversion in valuation spread, especially if U.S. earnings breadth remains narrow. Over the next 3-12 months, the catalyst path is not a single macro shock but a steady accumulation of reasons to diversify: policy uncertainty, supply-chain regionalization, and rising scrutiny of U.S. fiscal credibility. That creates a favorable backdrop for allocators to add international beta through low-cost wrappers, but the real alpha likely sits in targeted exposure to beneficiaries of AI capex and industrial automation outside the U.S.

The contrarian view is that the trade may be overbought tactically even if underowned strategically. VXUS has already outperformed on a 12-month basis, so near-term upside could stall if the dollar stabilizes or if U.S. growth reaccelerates on earnings revisions. Also, a lot of the quality exposure inside international indexes is concentrated in a few Taiwan/Europe semis and equipment names; that means the “international diversification” story can quietly become a disguised semiconductor trade rather than a true macro hedge.

Key Decisions for Investors

• Add VXUS on weakness as a 3-6 month strategic hedge, sizing 3-5% of portfolio; upside is diversification and possible dollar-beta support, but trim if the U.S. dollar index rebounds sharply or U.S. earnings breadth improves.
• Go long TSM / short a U.S.-listed mega-cap semiconductor basket over 1-3 months; thesis is that global AI and foundry capex remains sticky while U.S. AI beneficiaries are more valuation-sensitive. Target 1.5-2.0x upside on the spread with a tight stop if U.S. hyperscaler capex re-accelerates.
• Go long ASML on 6-12 month horizon via equity or call spreads; risk/reward favors a rerating if equipment order visibility improves, but monitor China-related headline risk as the main drawdown catalyst.
• Pair trade: long VXUS / short SPY in a 6-9 month relative-value book if U.S. valuations remain stretched and macro volatility rises; expect modest carry drag but asymmetric pay-off if leadership rotates away from the U.S.
• Avoid chasing NFLX or NVDA as ‘international diversification’ proxies; they are still primarily U.S. equity-duration exposures and will not hedge the same macro factors as true non-U.S. revenue or domicile exposure.